Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse
NCT06738537
Summary
This is a qualitative and quantitative study that seeks to obtain information from patients with degenerative mitral valve prolapse and providers regarding factors important in deciding between surgical mitral valve repair (MVR) and transcatheter edge-to-edge repair (TEER). Findings from this study will provide data that can be used to develop decision aids that can assist patients in decision making between these two therapies and assist providers in integrating shared decision making the within the multidisciplinary heart valve team.
Eligibility
Inclusion Criteria: * Age 21 years and older * Diagnosis of degenerative mitral valve regurgitation Exclusion Criteria: * Non-English speaking * Unable to consent on own behalf * Previous mitral surgery
Conditions2
Locations5 sites
California
1 siteMissouri
1 siteNew York
1 siteOhio
1 siteWest Virginia
1 siteBrowse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06738537